![Mark Groper](https://assets.obj.ca/2022/07/xqoCGhN5-Groper-10-_Outlook-1-300x272.jpg)
Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored